HEADER IMMUNE SYSTEM 25-AUG-05 2ATP TITLE CRYSTAL STRUCTURE OF A CD8AB HETERODIMER COMPND MOL_ID: 1; COMPND 2 MOLECULE: T-CELL SURFACE GLYCOPROTEIN CD8 ALPHA CHAIN; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: CD8A ECTODOMAIN FRAGMENT; COMPND 5 SYNONYM: T-CELL SURFACE GLYCOPROTEIN LYT-2; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: ARTIFACT LINKER; COMPND 9 CHAIN: E, F; COMPND 10 FRAGMENT: A PEPTIDE USED TO CONNECT CD8A C-TERMINAL AND CD8B N- COMPND 11 TERMINAL; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: T-CELL SURFACE GLYCOPROTEIN CD8 BETA CHAIN; COMPND 15 CHAIN: B, D; COMPND 16 FRAGMENT: CD8B ECTODOMAIN FRAGMENT; COMPND 17 SYNONYM: T-CELL SURFACE GLYCOPROTEIN LYT-3, T-CELL MEMBRANE COMPND 18 GLYCOPROTEIN LY-3; COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: CD8A, LYT-2, LYT2; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: CHO-LEC 3.8.2.1; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PEE14; SOURCE 12 MOL_ID: 2; SOURCE 13 SYNTHETIC: YES; SOURCE 14 OTHER_DETAILS: SYNTHETIC LINKER; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 17 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 18 ORGANISM_TAXID: 10090; SOURCE 19 GENE: CD8B, LYT-3, LYT3; SOURCE 20 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 21 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 22 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 23 EXPRESSION_SYSTEM_STRAIN: CHO-LEC 3.8.2.1; SOURCE 24 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 25 EXPRESSION_SYSTEM_PLASMID: PEE14 KEYWDS CD8AB, CD8AA, MHC, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR H.C.CHANG,K.TAN,J.OUYANG,E.PARISINI,J.H.LIU,Y.LE,X.WANG,E.L.REINHERZ, AUTHOR 2 J.H.WANG REVDAT 6 30-OCT-24 2ATP 1 REMARK REVDAT 5 23-AUG-23 2ATP 1 HETSYN REVDAT 4 29-JUL-20 2ATP 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE REVDAT 3 13-JUL-11 2ATP 1 VERSN REVDAT 2 24-FEB-09 2ATP 1 VERSN REVDAT 1 27-DEC-05 2ATP 0 JRNL AUTH H.C.CHANG,K.TAN,J.OUYANG,E.PARISINI,J.H.LIU,Y.LE,X.WANG, JRNL AUTH 2 E.L.REINHERZ,J.H.WANG JRNL TITL STRUCTURAL AND MUTATIONAL ANALYSES OF A CD8ALPHABETA JRNL TITL 2 HETERODIMER AND COMPARISON WITH THE CD8ALPHAALPHA HOMODIMER. JRNL REF IMMUNITY V. 23 661 2005 JRNL REFN ISSN 1074-7613 JRNL PMID 16356863 JRNL DOI 10.1016/J.IMMUNI.2005.11.002 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.9 REMARK 3 NUMBER OF REFLECTIONS : 19292 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.242 REMARK 3 FREE R VALUE : 0.294 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1497 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.49 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.4060 REMARK 3 BIN FREE R VALUE : 0.4570 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 121 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3750 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 44 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 51.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM SIGMAA (A) : 0.60 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : 1.913 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 27.84 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.649 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2ATP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-SEP-05. REMARK 100 THE DEPOSITION ID IS D_1000034298. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-DEC-04 REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97910 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21001 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.44000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASES REMARK 200 STARTING MODEL: PDB ENTRY 1BQH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG4000, 0.2M (NH4)2SO4, 0.1 M REMARK 280 TRIS , PH 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 46.32750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, F, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 1 REMARK 465 PRO A 2 REMARK 465 GLN A 3 REMARK 465 VAL A 122 REMARK 465 ALA E 1 REMARK 465 GLY E 2 REMARK 465 SER E 3 REMARK 465 ALA E 4 REMARK 465 ASP E 5 REMARK 465 ASP E 6 REMARK 465 ALA E 7 REMARK 465 ARG E 8 REMARK 465 LYS E 9 REMARK 465 ASP E 10 REMARK 465 ALA E 11 REMARK 465 ALA E 12 REMARK 465 ARG E 13 REMARK 465 LYS E 14 REMARK 465 ASP E 15 REMARK 465 ASP E 16 REMARK 465 ALA E 17 REMARK 465 ARG E 18 REMARK 465 LYS E 19 REMARK 465 ASP E 20 REMARK 465 ASP E 21 REMARK 465 ALA E 22 REMARK 465 LYS C 1 REMARK 465 PRO C 2 REMARK 465 GLN C 3 REMARK 465 ALA F 1 REMARK 465 GLY F 2 REMARK 465 SER F 3 REMARK 465 ALA F 4 REMARK 465 ASP F 5 REMARK 465 ASP F 6 REMARK 465 ALA F 7 REMARK 465 ARG F 8 REMARK 465 LYS F 9 REMARK 465 ASP F 10 REMARK 465 ALA F 11 REMARK 465 ALA F 12 REMARK 465 ARG F 13 REMARK 465 LYS F 14 REMARK 465 ASP F 15 REMARK 465 ASP F 16 REMARK 465 ALA F 17 REMARK 465 ARG F 18 REMARK 465 LYS F 19 REMARK 465 ASP F 20 REMARK 465 ASP F 21 REMARK 465 ALA F 22 REMARK 465 ARG F 23 REMARK 465 LYS F 24 REMARK 465 ASP F 25 REMARK 465 GLY F 26 REMARK 465 SER F 27 REMARK 465 LYS D 27 REMARK 465 LEU D 28 REMARK 465 THR D 29 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 28 CA - CB - CG ANGL. DEV. = -14.6 DEGREES REMARK 500 SER C 33 N - CA - C ANGL. DEV. = 19.4 DEGREES REMARK 500 GLN C 34 N - CA - C ANGL. DEV. = -21.2 DEGREES REMARK 500 ILE D 25 N - CA - C ANGL. DEV. = 25.7 DEGREES REMARK 500 PRO D 40 C - N - CA ANGL. DEV. = 10.4 DEGREES REMARK 500 PRO D 40 C - N - CD ANGL. DEV. = -13.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 5 152.20 -48.01 REMARK 500 SER A 71 -22.60 95.19 REMARK 500 LEU A 74 -2.60 -174.98 REMARK 500 ASN A 83 -12.22 -141.35 REMARK 500 ASN A 90 -84.92 -51.21 REMARK 500 PHE A 92 108.08 -52.21 REMARK 500 SER A 93 -158.17 -111.18 REMARK 500 ASN A 107 71.79 53.43 REMARK 500 SER A 108 9.11 59.67 REMARK 500 SER E 27 22.15 -74.04 REMARK 500 SER E 28 -116.36 25.24 REMARK 500 ASN B 13 4.46 80.01 REMARK 500 HIS B 14 -168.11 -101.64 REMARK 500 SER B 24 -158.20 -169.41 REMARK 500 SER B 26 65.81 -62.70 REMARK 500 LYS B 27 97.93 -68.69 REMARK 500 LEU B 28 98.00 -19.44 REMARK 500 PRO B 40 80.90 -42.64 REMARK 500 LYS B 41 -83.46 164.98 REMARK 500 LYS B 65 -9.65 68.90 REMARK 500 ARG B 67 42.43 37.13 REMARK 500 ASP B 92 177.89 174.51 REMARK 500 SER B 101 69.12 -119.37 REMARK 500 LYS B 103 137.36 1.99 REMARK 500 ALA C 16 -168.19 -107.23 REMARK 500 SER C 33 130.91 -16.56 REMARK 500 SER C 45 -145.19 -47.95 REMARK 500 LYS C 46 -4.97 79.24 REMARK 500 VAL C 53 -69.24 -102.96 REMARK 500 SER C 59 -70.63 -103.17 REMARK 500 ASN C 61 56.96 -91.79 REMARK 500 ASN C 70 -81.15 -18.51 REMARK 500 SER C 72 -123.14 -81.28 REMARK 500 LYS C 73 14.45 -177.62 REMARK 500 THR C 81 -148.85 63.50 REMARK 500 PHE C 92 66.75 -68.33 REMARK 500 SER D 24 79.92 61.88 REMARK 500 ASP D 39 69.58 -108.55 REMARK 500 PRO D 40 22.54 20.47 REMARK 500 LYS D 41 -43.38 -159.37 REMARK 500 LEU D 48 -63.79 -93.80 REMARK 500 SER D 54 42.84 77.42 REMARK 500 LYS D 55 -19.85 171.88 REMARK 500 SER D 62 36.25 -87.55 REMARK 500 ASP D 75 55.87 -104.16 REMARK 500 ASP D 92 -175.90 173.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BQH RELATED DB: PDB REMARK 900 MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8 REMARK 900 RELATED ID: 1NEZ RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION: REMARK 900 IMPLICATIONS FOR MEMORY T CELL GENERATION, CO-RECEPTOR PREFERENCE REMARK 900 AND AFFINITY DBREF 2ATP A 1 122 UNP P01731 CD8A_MOUSE 28 149 DBREF 2ATP C 1 122 UNP P01731 CD8A_MOUSE 28 149 DBREF 2ATP B 1 115 UNP P10300 CD8B_MOUSE 22 136 DBREF 2ATP D 1 115 UNP P10300 CD8B_MOUSE 22 136 DBREF 2ATP E 1 29 PDB 2ATP 2ATP 1 29 DBREF 2ATP F 1 29 PDB 2ATP 2ATP 1 29 SEQRES 1 A 122 LYS PRO GLN ALA PRO GLU LEU ARG ILE PHE PRO LYS LYS SEQRES 2 A 122 MET ASP ALA GLU LEU GLY GLN LYS VAL ASP LEU VAL CYS SEQRES 3 A 122 GLU VAL LEU GLY SER VAL SER GLN GLY CYS SER TRP LEU SEQRES 4 A 122 PHE GLN ASN SER SER SER LYS LEU PRO GLN PRO THR PHE SEQRES 5 A 122 VAL VAL TYR MET ALA SER SER HIS ASN LYS ILE THR TRP SEQRES 6 A 122 ASP GLU LYS LEU ASN SER SER LYS LEU PHE SER ALA MET SEQRES 7 A 122 ARG ASP THR ASN ASN LYS TYR VAL LEU THR LEU ASN LYS SEQRES 8 A 122 PHE SER LYS GLU ASN GLU GLY TYR TYR PHE CYS SER VAL SEQRES 9 A 122 ILE SER ASN SER VAL MET TYR PHE SER SER VAL VAL PRO SEQRES 10 A 122 VAL LEU GLN LYS VAL SEQRES 1 E 29 ALA GLY SER ALA ASP ASP ALA ARG LYS ASP ALA ALA ARG SEQRES 2 E 29 LYS ASP ASP ALA ARG LYS ASP ASP ALA ARG LYS ASP GLY SEQRES 3 E 29 SER SER ALA SEQRES 1 B 115 LEU ILE GLN THR PRO SER SER LEU LEU VAL GLN THR ASN SEQRES 2 B 115 HIS THR ALA LYS MET SER CYS GLU VAL LYS SER ILE SER SEQRES 3 B 115 LYS LEU THR SER ILE TYR TRP LEU ARG GLU ARG GLN ASP SEQRES 4 B 115 PRO LYS ASP LYS TYR PHE GLU PHE LEU ALA SER TRP SER SEQRES 5 B 115 SER SER LYS GLY VAL LEU TYR GLY GLU SER VAL ASP LYS SEQRES 6 B 115 LYS ARG ASN ILE ILE LEU GLU SER SER ASP SER ARG ARG SEQRES 7 B 115 PRO PHE LEU SER ILE MET ASN VAL LYS PRO GLU ASP SER SEQRES 8 B 115 ASP PHE TYR PHE CYS ALA THR VAL GLY SER PRO LYS MET SEQRES 9 B 115 VAL PHE GLY THR GLY THR LYS LEU THR VAL VAL SEQRES 1 C 122 LYS PRO GLN ALA PRO GLU LEU ARG ILE PHE PRO LYS LYS SEQRES 2 C 122 MET ASP ALA GLU LEU GLY GLN LYS VAL ASP LEU VAL CYS SEQRES 3 C 122 GLU VAL LEU GLY SER VAL SER GLN GLY CYS SER TRP LEU SEQRES 4 C 122 PHE GLN ASN SER SER SER LYS LEU PRO GLN PRO THR PHE SEQRES 5 C 122 VAL VAL TYR MET ALA SER SER HIS ASN LYS ILE THR TRP SEQRES 6 C 122 ASP GLU LYS LEU ASN SER SER LYS LEU PHE SER ALA MET SEQRES 7 C 122 ARG ASP THR ASN ASN LYS TYR VAL LEU THR LEU ASN LYS SEQRES 8 C 122 PHE SER LYS GLU ASN GLU GLY TYR TYR PHE CYS SER VAL SEQRES 9 C 122 ILE SER ASN SER VAL MET TYR PHE SER SER VAL VAL PRO SEQRES 10 C 122 VAL LEU GLN LYS VAL SEQRES 1 F 29 ALA GLY SER ALA ASP ASP ALA ARG LYS ASP ALA ALA ARG SEQRES 2 F 29 LYS ASP ASP ALA ARG LYS ASP ASP ALA ARG LYS ASP GLY SEQRES 3 F 29 SER SER ALA SEQRES 1 D 115 LEU ILE GLN THR PRO SER SER LEU LEU VAL GLN THR ASN SEQRES 2 D 115 HIS THR ALA LYS MET SER CYS GLU VAL LYS SER ILE SER SEQRES 3 D 115 LYS LEU THR SER ILE TYR TRP LEU ARG GLU ARG GLN ASP SEQRES 4 D 115 PRO LYS ASP LYS TYR PHE GLU PHE LEU ALA SER TRP SER SEQRES 5 D 115 SER SER LYS GLY VAL LEU TYR GLY GLU SER VAL ASP LYS SEQRES 6 D 115 LYS ARG ASN ILE ILE LEU GLU SER SER ASP SER ARG ARG SEQRES 7 D 115 PRO PHE LEU SER ILE MET ASN VAL LYS PRO GLU ASP SER SEQRES 8 D 115 ASP PHE TYR PHE CYS ALA THR VAL GLY SER PRO LYS MET SEQRES 9 D 115 VAL PHE GLY THR GLY THR LYS LEU THR VAL VAL MODRES 2ATP ASN A 42 ASN GLYCOSYLATION SITE MODRES 2ATP ASN C 42 ASN GLYCOSYLATION SITE MODRES 2ATP ASN D 13 ASN GLYCOSYLATION SITE HET NAG A 242 14 HET NAG C 242 14 HET NAG D 213 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 7 NAG 3(C8 H15 N O6) FORMUL 10 HOH *44(H2 O) HELIX 1 1 GLU B 61 ASP B 64 5 4 HELIX 2 2 LYS B 87 SER B 91 5 5 HELIX 3 3 GLU C 67 ASN C 70 5 4 HELIX 4 4 SER C 93 ASN C 96 5 4 HELIX 5 5 LYS D 65 ARG D 67 5 3 HELIX 6 6 LYS D 87 SER D 91 5 5 SHEET 1 A 4 LEU A 7 PHE A 10 0 SHEET 2 A 4 VAL A 22 VAL A 28 -1 O VAL A 25 N PHE A 10 SHEET 3 A 4 LYS A 84 LEU A 89 -1 O LEU A 87 N LEU A 24 SHEET 4 A 4 SER A 76 ASP A 80 -1 N ASP A 80 O LYS A 84 SHEET 1 B 6 MET A 14 ALA A 16 0 SHEET 2 B 6 VAL A 116 GLN A 120 1 O PRO A 117 N MET A 14 SHEET 3 B 6 GLY A 98 SER A 106 -1 N TYR A 100 O VAL A 116 SHEET 4 B 6 GLY A 35 ASN A 42 -1 N LEU A 39 O PHE A 101 SHEET 5 B 6 THR A 51 ALA A 57 -1 O VAL A 54 N TRP A 38 SHEET 6 B 6 ILE A 63 TRP A 65 -1 O THR A 64 N TYR A 55 SHEET 1 C 4 MET A 14 ALA A 16 0 SHEET 2 C 4 VAL A 116 GLN A 120 1 O PRO A 117 N MET A 14 SHEET 3 C 4 GLY A 98 SER A 106 -1 N TYR A 100 O VAL A 116 SHEET 4 C 4 VAL A 109 PHE A 112 -1 O TYR A 111 N VAL A 104 SHEET 1 D 4 LEU B 1 THR B 4 0 SHEET 2 D 4 ALA B 16 VAL B 22 -1 O SER B 19 N THR B 4 SHEET 3 D 4 PHE B 80 ILE B 83 -1 O LEU B 81 N MET B 18 SHEET 4 D 4 ILE B 69 GLU B 72 -1 N GLU B 72 O PHE B 80 SHEET 1 E 6 SER B 7 VAL B 10 0 SHEET 2 E 6 THR B 110 VAL B 114 1 O LYS B 111 N LEU B 8 SHEET 3 E 6 ASP B 92 VAL B 99 -1 N ASP B 92 O LEU B 112 SHEET 4 E 6 SER B 30 GLN B 38 -1 N TYR B 32 O ALA B 97 SHEET 5 E 6 LYS B 43 SER B 52 -1 O LEU B 48 N TRP B 33 SHEET 6 E 6 GLY B 56 TYR B 59 -1 O GLY B 56 N SER B 52 SHEET 1 F 4 SER B 7 VAL B 10 0 SHEET 2 F 4 THR B 110 VAL B 114 1 O LYS B 111 N LEU B 8 SHEET 3 F 4 ASP B 92 VAL B 99 -1 N ASP B 92 O LEU B 112 SHEET 4 F 4 MET B 104 PHE B 106 -1 O VAL B 105 N THR B 98 SHEET 1 G 4 GLU C 6 PHE C 10 0 SHEET 2 G 4 VAL C 22 LEU C 29 -1 O GLU C 27 N ARG C 8 SHEET 3 G 4 LYS C 84 LEU C 89 -1 O LEU C 87 N LEU C 24 SHEET 4 G 4 PHE C 75 ASP C 80 -1 N SER C 76 O THR C 88 SHEET 1 H 5 ILE C 63 TRP C 65 0 SHEET 2 H 5 THR C 51 MET C 56 -1 N TYR C 55 O THR C 64 SHEET 3 H 5 CYS C 36 ASN C 42 -1 N TRP C 38 O VAL C 54 SHEET 4 H 5 GLY C 98 SER C 106 -1 O PHE C 101 N LEU C 39 SHEET 5 H 5 VAL C 109 PHE C 112 -1 O VAL C 109 N SER C 106 SHEET 1 I 5 ILE C 63 TRP C 65 0 SHEET 2 I 5 THR C 51 MET C 56 -1 N TYR C 55 O THR C 64 SHEET 3 I 5 CYS C 36 ASN C 42 -1 N TRP C 38 O VAL C 54 SHEET 4 I 5 GLY C 98 SER C 106 -1 O PHE C 101 N LEU C 39 SHEET 5 I 5 VAL C 116 VAL C 118 -1 O VAL C 118 N GLY C 98 SHEET 1 J 4 ILE D 2 THR D 4 0 SHEET 2 J 4 ALA D 16 GLU D 21 -1 O SER D 19 N THR D 4 SHEET 3 J 4 PHE D 80 ILE D 83 -1 O LEU D 81 N MET D 18 SHEET 4 J 4 ILE D 69 GLU D 72 -1 N GLU D 72 O PHE D 80 SHEET 1 K 6 SER D 7 GLN D 11 0 SHEET 2 K 6 THR D 110 VAL D 115 1 O LYS D 111 N LEU D 8 SHEET 3 K 6 ASP D 92 VAL D 99 -1 N ASP D 92 O LEU D 112 SHEET 4 K 6 ILE D 31 ASP D 39 -1 N LEU D 34 O PHE D 95 SHEET 5 K 6 ASP D 42 SER D 52 -1 O TRP D 51 N ILE D 31 SHEET 6 K 6 GLY D 56 TYR D 59 -1 O LEU D 58 N SER D 50 SHEET 1 L 4 SER D 7 GLN D 11 0 SHEET 2 L 4 THR D 110 VAL D 115 1 O LYS D 111 N LEU D 8 SHEET 3 L 4 ASP D 92 VAL D 99 -1 N ASP D 92 O LEU D 112 SHEET 4 L 4 MET D 104 PHE D 106 -1 O VAL D 105 N THR D 98 SSBOND 1 CYS A 26 CYS A 102 1555 1555 2.03 SSBOND 2 CYS B 20 CYS B 96 1555 1555 2.52 SSBOND 3 CYS C 26 CYS C 102 1555 1555 2.03 SSBOND 4 CYS D 20 CYS D 96 1555 1555 2.83 LINK ND2 ASN A 42 C1 NAG A 242 1555 1555 1.46 LINK C ALA E 29 N LEU B 1 1555 1555 1.33 LINK ND2 ASN C 42 C1 NAG C 242 1555 1555 1.46 LINK C ALA F 29 N LEU D 1 1555 1555 1.33 LINK ND2 ASN D 13 C1 NAG D 213 1555 1555 1.47 CISPEP 1 PHE A 10 PRO A 11 0 -0.07 CISPEP 2 THR B 4 PRO B 5 0 -0.01 CISPEP 3 SER B 101 PRO B 102 0 -0.07 CISPEP 4 PHE C 10 PRO C 11 0 -0.15 CISPEP 5 THR D 4 PRO D 5 0 -0.28 CISPEP 6 SER D 101 PRO D 102 0 -0.41 CRYST1 37.668 92.655 79.330 90.00 95.67 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026548 0.000000 0.002636 0.00000 SCALE2 0.000000 0.010793 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012668 0.00000